| pubmed-article:3056241 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3056241 | lifeskim:mentions | umls-concept:C0026922 | lld:lifeskim |
| pubmed-article:3056241 | lifeskim:mentions | umls-concept:C0031375 | lld:lifeskim |
| pubmed-article:3056241 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:3056241 | lifeskim:mentions | umls-concept:C1707391 | lld:lifeskim |
| pubmed-article:3056241 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:3056241 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:3056241 | pubmed:dateCreated | 1988-12-22 | lld:pubmed |
| pubmed-article:3056241 | pubmed:abstractText | Structure-activity relationships of phenazines against Mycobacterium leprae were investigated by using an in vitro radiorespirometric assay. In general, activity in ascending order was observed in compounds containing no chlorine atoms, a monochlorinated phenazine nucleus, and chlorines in the para positions of both the anilino and phenyl rings. The most active compounds contained a 2,2,6,6-tetramethylpiperidine substitution at the imino nitrogen. Most of these chlorinated phenazines were considerably more active in vitro than clofazimine (B663). | lld:pubmed |
| pubmed-article:3056241 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3056241 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3056241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3056241 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3056241 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:3056241 | pubmed:issn | 0066-4804 | lld:pubmed |
| pubmed-article:3056241 | pubmed:author | pubmed-author:O'SullivanJ... | lld:pubmed |
| pubmed-article:3056241 | pubmed:author | pubmed-author:FranzblauS... | lld:pubmed |
| pubmed-article:3056241 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3056241 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:3056241 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3056241 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3056241 | pubmed:pagination | 1583-5 | lld:pubmed |
| pubmed-article:3056241 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:3056241 | pubmed:meshHeading | pubmed-meshheading:3056241-... | lld:pubmed |
| pubmed-article:3056241 | pubmed:meshHeading | pubmed-meshheading:3056241-... | lld:pubmed |
| pubmed-article:3056241 | pubmed:meshHeading | pubmed-meshheading:3056241-... | lld:pubmed |
| pubmed-article:3056241 | pubmed:meshHeading | pubmed-meshheading:3056241-... | lld:pubmed |
| pubmed-article:3056241 | pubmed:meshHeading | pubmed-meshheading:3056241-... | lld:pubmed |
| pubmed-article:3056241 | pubmed:meshHeading | pubmed-meshheading:3056241-... | lld:pubmed |
| pubmed-article:3056241 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3056241 | pubmed:articleTitle | Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro. | lld:pubmed |
| pubmed-article:3056241 | pubmed:affiliation | Gillis W. Long Hansen's Disease Center, Carville, Louisiana 70721. | lld:pubmed |
| pubmed-article:3056241 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3056241 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3056241 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3056241 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3056241 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3056241 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3056241 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3056241 | lld:pubmed |
